Lv1
65 积分 2020-08-02 加入
Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity Modulated Radiation Therapy for Intact Cervical Cancer: An Update
11天前
已完结
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2个月前
已完结
American Brachytherapy Society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers
3个月前
已完结
Reirradiation with advanced brachytherapy techniques in recurrent GYN cancers
3个月前
已关闭
Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain
3个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
6个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
6个月前
已完结
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
7个月前
已完结
Optimal prophylactic para-aortic radiotherapy in locally advanced cervical cancer: anatomy-based versus margin-based delineation
7个月前
已完结
皖公网安备34019202002308
